A specific antidote for dabigatran: functional and structural characterizationFelix Schiele, Tobias Litzenburger, Eliud Sepulveda et al.|DORA PSI (Paul Scherrer Institute)|2013Cited by 0
An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels<em> in vivo</em>Felix Schiele, Herbert Nar, John E. Park et al.|DORA PSI (Paul Scherrer Institute)|2014Cited by 0